Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 14.81 AUD 1.72% Market Closed
Market Cap: 5B AUD

Intrinsic Value

The intrinsic value of one TLX stock under the Base Case scenario is hidden AUD. Compared to the current market price of 14.81 AUD, Telix Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLX Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Telix Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

TLX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether TLX usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about TLX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TLX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Telix Pharmaceuticals Ltd.

Explain Valuation
Compare TLX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Telix’s reliance on complex radiopharmaceutical manufacturing and distribution channels introduces significant logistical and cost risks, potentially limiting timely and efficient market penetration.

Bull Theses

Telix’s portfolio of targeted radiopharmaceuticals addresses high-unmet-need oncology indications, positioning the firm for rapid market adoption if efficacy and safety data continue to be strong.

Show More Less
How do you feel about TLX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Telix Pharmaceuticals Ltd

Current Assets 398m
Cash & Short-Term Investments 207.2m
Receivables 129.5m
Other Current Assets 61.3m
Non-Current Assets 791.9m
Long-Term Investments 36.7m
PP&E 74.2m
Intangibles 584.2m
Other Non-Current Assets 96.9m
Current Liabilities 298.6m
Accounts Payable 51.7m
Accrued Liabilities 54.7m
Other Current Liabilities 192.2m
Non-Current Liabilities 469.4m
Long-Term Debt 397.2m
Other Non-Current Liabilities 72.2m
Efficiency

Free Cash Flow Analysis
Telix Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Telix Pharmaceuticals Ltd

Revenue
662.2m AUD
Cost of Revenue
-305m AUD
Gross Profit
357.2m AUD
Operating Expenses
-329.3m AUD
Operating Income
28m AUD
Other Expenses
-17.1m AUD
Net Income
10.8m AUD
Fundamental Scores

TLX Profitability Score
Profitability Due Diligence

Telix Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Operating Margin is Increasing
hidden
Profitability
Score

Telix Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TLX Solvency Score
Solvency Due Diligence

Telix Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Low D/E
hidden
Solvency
Score

Telix Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 28.34 AUD with a low forecast of 22.83 AUD and a high forecast of 36.75 AUD.

Lowest
Price Target
22.83 AUD
54% Upside
Average
Price Target
28.34 AUD
91% Upside
Highest
Price Target
36.75 AUD
148% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Telix Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for TLX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

TLX News

Other Videos
What is the Intrinsic Value of one TLX stock?

The intrinsic value of one TLX stock under the Base Case scenario is hidden AUD.

Is TLX stock undervalued or overvalued?

Compared to the current market price of 14.81 AUD, Telix Pharmaceuticals Ltd is hidden .

Back to Top